Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

WHO and ESCEO partner to develop roadmap for bone health and ageing

Over 1.7 billion people globally live with musculoskeletal conditions

- PMLiVE

Sanofi reports positive new data for multiple sclerosis treatment tolebrutinib

It is estimated that there are over 130,000 people living with the condition in the UK alone

- PMLiVE

FDA authorises first at-home COVID-19 and flu test for emergency use

The single-use test uses nasal swab samples and provides results in about 30 minutes

- PMLiVE

A relentless commitment to neuroscience

Hundreds of millions of people worldwide are affected by neurological and psychiatric disorders and they are the largest cause of disability worldwide

Pharmaceutical companies reduce own greenhouse gas emissions, but action on supply chains needed

DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public...

Oxford PharmaGenesis

- PMLiVE

Kate Shaw comments the appointment of an independent review on clinical trials in the UK.

The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...

Innovative Trials

Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva

Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...

Medscape Education

- PMLiVE

Improving the Clinical Trial Experience: Why, How, and What?

In this webinar Langland will speak to Jonathan Moshinsky, Co-Founder and CEO of Stitch, a technology start-up supporting participant retention by enabling in-study feedback, and Sofia Fionda, Co-Founder of Boxee...

- PMLiVE

Sanofi and Sobi’s once-weekly haemophilia A treatment approved by FDA

Current factor VIII therapies usually require patients to receive treatment every two days

- PMLiVE

Moderna/Merck’s skin cancer therapy given FDA breakthrough therapy designation

Nearly 325,000 new cases of melanoma were diagnosed globally in 2020

- PMLiVE

Roche launches two antibodies to identify mutation status in brain cancer patients

Knowing a patient’s key mutations can help clinicians provide personalised care

- PMLiVE

Managing COPD: the 2023 GOLD report

The annual report provides new, essential updates on screening, therapeutic interventions and adherence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links